Esquire Financial Holdings, Inc. filings document the public-company record for a Maryland financial holding company whose common stock trades on Nasdaq under ESQ and whose bank subsidiary is Esquire Bank, National Association.
The filing record includes Form 8-K disclosures for earnings releases, Regulation FD presentations, regular dividend actions, material agreements, and director or committee changes. Proxy materials cover annual-meeting governance, director matters, executive compensation, equity awards, pay-versus-performance data, and shareholder voting matters. The disclosures also identify the company's capital structure, banking subsidiary, Nasdaq-listed common stock, and governance framework.
Esquire Financial Holdings, Inc. (ESQ) reports that Vice Chairman, President & CEO Andrew C. Sagliocca sold 10,000 shares of common stock on September 18, 2026 in an open-market transaction at a weighted average price of $122.73 per share, with prices ranging from $122.61 to $123.50.
After this sale, he holds 288,798 shares directly, which include multiple grants of restricted stock scheduled to vest in three equal annual installments beginning on various dates from December 16, 2024 through January 29, 2029. No Rule 10b5-1 trading plan is indicated.
Esquire Financial Holdings, Inc. (ESQ) received a notice under Rule 144 that Andrew C. Sagliocca plans to sell 10,000 shares of its common stock. The filing lists an aggregate market value of $127,303.30 for these shares, with 12,094,583 shares outstanding and an approximate sale date of September 18, 2026. The seller previously received an RSA Stock Grant of 298,798 shares on December 16, 2024.
Esquire Financial Holdings, Inc. (ESQ) reported that director and President of the Chicago Bank Division Michael G. O'Rourke exercised stock options on September 14, 2026 to acquire 5,953 shares of common stock at an exercise price of $19.57 per share. Following this transaction, he owned 72,679 common shares directly and 18,630 common shares indirectly through an IRA. The options exercised were fully vested, and he continues to hold additional stock option awards with exercise prices ranging from $22.41 to $111.14 per share and expiration dates extending through May 26, 2036. No Rule 10b5-1 trading plan is reported for these transactions.
Esquire Financial Holdings, Inc. (ESQ) director Richard T. Powers reported a bona fide gift of 51,380 shares of common stock on August 25, 2026, transferring them to a Family Trust where they are now held indirectly. Following the transaction, he holds 6,853 shares directly, which include multiple tranches of restricted stock vesting between December 2024 and December 2027.
Esquire Financial Holdings, Inc. director Anthony Coelho exercised stock options for 20,000 shares of common stock on August 7, 2026 at an exercise price of $12.50 per share. In connection with this exercise, 1,902 shares of common stock were delivered or withheld for payment of exercise price or tax liability at $131.38 per share. The stock options exercised were fully vested. Following these transactions, Coelho reported indirect holdings of 12,910 shares of common stock held by a trust and 36,000 shares held by an IRA, with portions of his reported common stock position consisting of restricted stock that vests in full or in installments between December 2024 and December 2027.
Esquire Financial Holdings reported solid growth for the six months ended June 30, 2026. Total assets rose to $2.51 billion from $2.37 billion, driven mainly by loans held for investment increasing to $1.90 billion from $1.76 billion. Total deposits grew to $2.18 billion from $2.06 billion, with most funding in savings, NOW and money market accounts.
For the quarter, net income was $12.98 million versus $11.89 million a year earlier; six‑month net income was $25.19 million versus $23.30 million. Diluted EPS was $1.49 for the quarter and $2.89 year‑to‑date, compared with $1.38 and $2.70, respectively. Net interest income for the first half increased to $69.75 million from $56.86 million, while provision for credit losses was $5.60 million, up from $5.03 million, and the allowance for credit losses stood at $24.72 million.
Subsequent to quarter‑end, Esquire completed a stock‑for‑stock merger with Signature Bancorporation. Signature shareholders received 2.671 Esquire shares per Signature share, for total consideration of about $466 million. Based on June 30, 2026 data, the combined company has roughly $4.8 billion in assets, $3.3 billion in loans, and $4.0 billion in deposits. Merger‑related expenses were $2.3 million year‑to‑date and are described as non‑recurring.
Mawer Investment Management Ltd. filed Amendment No. 2 to a Schedule 13G reporting its beneficial ownership in Esquire Financial Holdings, Inc. common stock. Mawer reports beneficial ownership of 583,871 shares of common stock, representing 6.76% of the outstanding class.
Mawer has sole voting power and sole dispositive power over all 583,871 shares, with no shared voting or dispositive power. The ownership percentage is based on 8,639,431 shares of Esquire common stock outstanding as of April 29, 2026, as reported by the issuer. The filing is signed by portfolio manager John Wilson on August 5, 2026.
Esquire Financial Holdings director Leonard Caronia exercised 2,232 stock options on August 4, 2026 at an exercise price of $19.57 per share, converting them into 2,232 shares of common stock held indirectly through a corporation. To cover the option exercise price or related tax obligations, 335 indirectly held shares were withheld at $130.31 per share. Caronia continues to hold multiple option grants on additional shares, many fully vested and others vesting annually beginning May 26, 2027, with exercise prices ranging from $22.41 to $111.14 and expirations from 2027 through 2036.
Esquire Financial Holdings, Inc. director Leonard Caronia reported merger-related equity acquisitions on August 1, 2026. In connection with the March 11, 2026 merger with Signature Bancorporation, 98864.0000 shares of common stock are indirectly held "By corporation," reflecting the 2.671-for-1 share conversion.
Multiple Signature stock options converted into options on Esquire common stock at adjusted exercise prices (for example, 2232.0000 shares at $19.5700 per share). Most converted options are fully vested, while the 950.0000-share series with a $111.1400 exercise price vests in five equal annual installments beginning May 26, 2027.
Esquire Financial Holdings, Inc. reporting person Michael G. O'Rourke, President of the Chicago Bank Division, reported multiple acquisitions on 2026-08-01 tied to the merger with Signature Bancorporation. Signature common stock and stock options converted into Esquire equity at a 2.671-for-1 ratio, resulting in 66726 common shares held directly and 18630 held indirectly via an IRA, plus several Esquire stock option awards with exercise prices from $19.5700 to $111.1400 per share. Most options are fully vested; one grant vests in five equal annual installments commencing on May 26, 2027.